Evidence map›Paper›PMID 37328820›Full record

ArticleBMC neurology2023

Sporadic late onset nemaline myopathy with concurrent dermatological symptoms responding to immunosuppressive treatment.

Anirban Nandy, Hatice Tankisi, Anne Bruun Krøigård, Maiken Glud Dalager, Marie Skov Hvidbjerg, Henrik Daa Schrøder, Izabella Obál

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Sporadic Late-Onset Nemaline Myopathy: Current Landscape.Current neurology and neuroscience reports · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Anirban NandyDepartment of Neurology, Aalborg University Hospital, Ladegaardsgade 5, Aalborg, 9000, Denmark.
Hatice TankisiDepartment of Clinical Neurophysiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus, 8200, Denmark.
Anne Bruun KrøigårdDepartment of Pathology, Odense University Hospital, J. B. Winsløws Vej 4, Odense, 5000, Denmark.
Maiken Glud DalagerDepartment of Dermatology, Aalborg University Hospital, Hobrovej 18-22, Aalborg, 9000, Denmark.
Marie Skov HvidbjergDepartment of Clinical Genetics, Aalborg University Hospital, Ladegaardsgade 5, Aalborg, 9000, Denmark.
Henrik Daa SchrøderDepartment of Pathology, Odense University Hospital, J. B. Winsløws Vej 4, Odense, 5000, Denmark.
Izabella ObálDepartment of Neurology, Aalborg University Hospital, Ladegaardsgade 5, Aalborg, 9000, Denmark. i.obal@rn.dk.
Aalborg University Hospital · DKOdense University Hospital · DKAalborg University · DKAarhus University Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSporadic late onset nemaline myopathy is a rare, progressive muscle disease, presenting in adulthood, mainly affecting proximal limb and bulbar muscles. Muscle biopsies show characteristic nemaline rods. The putative mechanism is considered immune-related. Other manifestations aside from neuromuscular symptoms have not been described previously. CASE PRESENTATION: We present a case with atypical sporadic late onset nemaline myopathy (SLONM) of a non-HIV, non-MGUS subtype, where skin manifestations preceded neuromuscular symptoms, and a residual thymus with the histology of thymic follicular hyperplasia was detected during the diagnostic workup. Thorough dermatological investigations could not explain the skin presentations. Muscle biopsy revealed variation in fiber diameter, ragged-red and COX-negative fibers associated with discrete fibrosis. Electron microscopy detected atrophic muscle fibres with disorganization of the myofibrils, nemaline rods and abnormal mitochondria. Single-fiber EMG suggested signs of a neuromuscular transmission defect, EMG showed signs of myopathy. Analyses of antibodies associated with myasthenia gravis were negative. The patient showed improvement after intravenous immunoglobulin treatment regarding both the skin and the muscle symptoms.

conclusionsOur case highlights the heterogeneity of SLONM with its varied spectrum of presentation. A unique combination of dermatological symptoms and SLONM could be seen with skin lesions as primary presenting symptoms. An association can be considered between the different manifestations, presumably based on immune etiology, where immunosuppressive therapy has been beneficial.

Indexed as

Myasthenia GravisMyopathies, NemalineHumansImmunoglobulins, IntravenousImmunosuppressive AgentsMusclesMuscle, SkeletalImmunoglobulins, IntravenousImmunosuppressive AgentsAutoimmunityMuscle diseaseNemalineSkin manifestationsSLONM

Identifiers

PMID37328820
PMCPMC10273545
OpenAlexW4380990986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.